Literature DB >> 1919620

The computational design of test compounds with potentially specific biological activity: histamine-H2 agonists derived from 5-HT/H2 antagonists.

S Topiol1, M Sabio.   

Abstract

The previously proposed models for the recognition and activation of 5-HT and histamine-H2 receptors, which were employed to explain the antagonist activity of LSD at both of these receptors, as well as the selective antagonism for H2 receptors by SKF-10856 and 9,10-dihydro-LSD, are used herein to design a compound to test the H2-receptor model. The design strategy attempts to construct a compound with potentially selective H2 agonism. The design scheme maintains features which were previously used to explain selective recognition of SKF-10856 and 9,10-dihydro-LSD as well as reintroduces the chemical features proposed to be responsible for H2 activation. The existence of the H2 recognition and activation features in the proposed compound is verified, in a previously proposed model, by computational studies of the molecular electrostatic potentials and shifts in the tautomeric preference.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919620     DOI: 10.1007/bf00124342

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  9 in total

1.  Tautomerism and the receptor action of histamine: a mechanistic model.

Authors:  H Weinstein; D Chou; C L Johnson; S Kang; J P Green
Journal:  Mol Pharmacol       Date:  1976-09       Impact factor: 4.436

2.  A molecular model for activation of a 5-hydroxytryptamine receptor.

Authors:  R Osman; S Topiol; L Rubenstein; H Weinstein
Journal:  Mol Pharmacol       Date:  1987-11       Impact factor: 4.436

3.  Theoretical studies on the activation mechanism of the histamine H2-receptor: the proton transfer between histamine and a receptor model.

Authors:  H Weinstein; A P Mazurek; R Osman; S Topiol
Journal:  Mol Pharmacol       Date:  1986-01       Impact factor: 4.436

4.  A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists.

Authors:  C D Strader; M R Candelore; W S Hill; R A Dixon; I S Sigal
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

5.  Molecular determinants for the agonist activity of 2-methylhistamine and 4-methylhistamine at H2-receptors.

Authors:  P Reggio; S Topiol; H Weinstein
Journal:  J Med Chem       Date:  1986-11       Impact factor: 7.446

6.  Molecular structure of LSD.

Authors:  R W Baker; C Chothia; P Pauling; H P Weber
Journal:  Science       Date:  1972-11-10       Impact factor: 47.728

7.  A theoretical investigation of histamine tautomerism.

Authors:  S Topiol; H Weinstein; R Osman
Journal:  J Med Chem       Date:  1984-11       Impact factor: 7.446

8.  Quantum chemical studies on molecular determinants for drug action.

Authors:  H Weinstein; R Osman; S Topiol; J P Green
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

9.  A molecular theory of recognition and activation at a 5-HT receptor based on a quantum chemical approach to structure activity relationships.

Authors:  R Osman; H Weinstein; S Topiol; L Rubenstein
Journal:  Clin Physiol Biochem       Date:  1985
  9 in total
  1 in total

1.  Multiconformational composite molecular potential fields in the analysis of drug action. I. Methodology and first evaluation using 5-HT and histamine action as examples.

Authors:  J G Vinter; K I Trollope
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.